Literature DB >> 6505258

Dose-response relationship for radiation therapy of recurrent, residual, and primarily inoperable colorectal cancer.

M Overgaard, J Overgaard, A Sell.   

Abstract

One hundred and thirteen patients with advanced locoregional recurrent (77), residual (18) or primarily inoperable (18) colorectal carcinoma were treated with radiotherapy. Eighty-five patients had locoregional disease only and 28 had both local disease and distant metastases. The treatment was given with varying dose levels (23-73 Gy) in daily fractions of approximately 2 Gy in 3-8 weeks. This dose variation allowed an evaluation of the dose-response relationship for radiation treatment of this tumour. A good subjective response was obtained in 63%. This effect showed no dose-response relationship except for doses greater than or equal to 56 Gy, where all patients received relief of symptoms. Eighty-two per cent of evaluable patients achieved an objective response (PR 53%, CR 29%). The frequency and duration of the complete responses showed a marked dose-response relationship. Thus, at doses greater than or equal to 56 Gy, a 2-year actuarial complete response rate of 40% was found compared with 7, 4 and 0% at doses of 46-55 Gy, 36-45 Gy and less than or equal to 35 Gy, respectively. The dose-response relationship for local control also influenced the survival rate, although a number of patients died from distant metastases even when local control was obtained. However, with regard to locoregional disease, the 2-year survival was 53% for patients with complete tumour regression but only 8% for patients without complete tumour regression.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6505258     DOI: 10.1016/s0167-8140(84)80003-1

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  11 in total

1.  Palliative treatment of rectal cancer: is radiotherapy alone a good option?

Authors:  Christopher G Willett; Leonard L Gunderson
Journal:  J Gastrointest Surg       Date:  2004 Mar-Apr       Impact factor: 3.452

2.  Three-dimensional conformal radiotherapy combined with FOLFOX4 chemotherapy for unresectable recurrent rectal cancer.

Authors:  Jian-Bin Hu; Xiao-Nan Sun; Qi-Chu Yang; Jing Xu; Qi Wang; Chao He
Journal:  World J Gastroenterol       Date:  2006-04-28       Impact factor: 5.742

3.  Effect of radiation therapy alone or in combination with surgery and/or chemotherapy on tumor and symptom control of recurrent rectal cancer.

Authors:  H P Knol; P E Hanssens; H J Rutten; T Wiggers
Journal:  Strahlenther Onkol       Date:  1997-01       Impact factor: 3.621

Review 4.  Radiation treatment for rectal cancer.

Authors:  B J Cummings
Journal:  World J Surg       Date:  1995 Mar-Apr       Impact factor: 3.352

Review 5.  Intensity-modulated radiation therapy for gastrointestinal tumors.

Authors:  Jeffrey J Meyer; Brian G Czito; Christopher G Willett
Journal:  Curr Oncol Rep       Date:  2008-05       Impact factor: 5.075

6.  Heterogeneity in antigenic expression and radiosensitivity in human colon carcinoma cell lines.

Authors:  G Frykholm; B Glimelius; S Richter; J Carlsson
Journal:  In Vitro Cell Dev Biol       Date:  1991-12

Review 7.  Pre-operative and post-operative radiotherapy and rectal cancer.

Authors:  L Påhlman; B Glimelius
Journal:  World J Surg       Date:  1992 Sep-Oct       Impact factor: 3.352

8.  Conservative surgery for low rectal carcinoma after high-dose radiation. Functional and oncologic results.

Authors:  P Rouanet; J M Fabre; J B Dubois; F Dravet; B Saint Aubert; J Pradel; M Ychou; C Solassol; H Pujol
Journal:  Ann Surg       Date:  1995-01       Impact factor: 12.969

9.  Dose Escalation with Simultaneous Integrated Boost (SIB) Using Volumetric Modulated Arc Therapy (VMAT) in Rectal Cancer.

Authors:  Abdullah Alsuhaibani; Ahmed Elashwah; Rana Mahmood; Alaa Abduljabbar; Samar Alhomoud; Luai Ashari; Shouki Bazarbashi; Ali Aljubran; Ahmed Alzahrani; Muhamed Mohiuddin; Hadeel Almanea; Hussah Alhussaini; Nasser AlSanea
Journal:  J Gastrointest Cancer       Date:  2018-07-14

10.  Predictors of Pathologic Complete Response Following Neoadjuvant Chemoradiotherapy for Rectal Cancer.

Authors:  Eisar Al-Sukhni; Kristopher Attwood; David M Mattson; Emmanuel Gabriel; Steven J Nurkin
Journal:  Ann Surg Oncol       Date:  2015-12-14       Impact factor: 5.344

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.